Table 4.
Characteristics and laboratory data of the COVID-19 patients based on severity
| None-severe group | Severe group | P value | |
|---|---|---|---|
| (n = 86) | (n = 20) | ||
| Age (years) | 40.23 ± 18.77 | 56.50 ± 17.01 | < 0.001 |
| Age group | < 0.001 | ||
| < 40 years | 54 (62.8%) | 3 (15%) | |
| ≥ 40 years | 32 (37.2%) | 17 (85%) | |
| Male sex | 39 (45.3%) | 11 (55%) | 0.29 |
| Diabetes mellitus | 16 (18.6%) | 9 (45%) | 0.01 |
| Hypertension | 9 (10.5%) | 7 (35%) | 0.01 |
| Cardiac disease | 5 (5.8%) | 3 (15%) | 0.17 |
| Hemoglobin (mg/dl) | 12.99 ± 1.39 | 11.77 ± 2.17 | < 0.001 |
| Leucocytes (103/μl) | 6.25 ± 3.69 | 8.67 ± 4.18 | 0.01 |
| Platelets (103/μl) | 268.26 ± 113.25 | 211.26 ± 115.98 | 0.06 |
| Lymphocyte (103/μl) | 1.92 ± 0.80 | 2.45 ± 1.61 | 0.13 |
| RDW (%) | 10.66 ± 4.90 | 13.18 ± 3.23 | 0.01 |
| C-reactive protein (mg/dl) | 66.10 ± 23.45 | 124.94 ± 12.34 | 0.07 |
| Ferritin (ng/ml) | 341.86 ± 123.45 | 940 ± 324.97 | < 0.001 |
| Alanine transaminase (μm/l) | 38.64 ± 4.95 | 37.54 ± 7.88 | 0.92 |
| Alanine transaminase (μm/l) | 31.06 ± 2.85 | 52.93 ± 10.51 | 0.06 |
| Urea (mg/dl) | 16.12 ± 2.44 | 8.72 ± 1.69 | 0.12 |
| Creatinine (mg/dl) | 60.31 ± 5.80 | 97.14 ± 14.20 | 0.25 |
Data expressed as frequency (percentage), mean (SD)
RDW red cell distribution width
P value was significant if < 0.05